Our findings highlight a novel mechanism of KHDRBS3 in HCC progression and provide the KHDRBS3/14-3-3ζ axis as a promising drug target for the treatment of HCC. The gene discussed is KHDRBS3; the disease is hepatocellular carcinoma.